Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management.

Frontiers in Immunology
Qin ZhangWeimin Li

Abstract

Immunotherapy that includes programmed cell death-1 (PD-1), programmed cell death- ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors has revolutionized the therapeutic strategy in multiple malignancies. Although it has achieved significant breakthrough in advanced non-small cell lung cancer patients, immune-related adverse events (irAEs) including checkpoint inhibitor pneumonitis (CIP), are widely reported. As the particularly worrisome and potentially lethal form of irAEs, CIP should be attached more importance. Especially in non-small cell lung cancer (NSCLC) patients, the features of CIP may be more complicated on account of the overlapping respiratory signs compromised by primary tumor following immunotherapy. Herein, we included the previous relevant reports and comprehensively summarized the characteristics, diagnosis, and management of CIP. We also discussed the future direction of optimal steroid therapeutic schedule for patients with CIP in NSCLC based on the current evidence.

References

Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun
Mar 28, 2002·Seminars in Radiation Oncology·Yuhchyau ChenPaul Okunieff
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly E BeckJames C Yang
Jul 6, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ikuo SekineTomohide Tamura
Nov 4, 2010·The Oncologist·Howard A Burris, Jane Hurtig
Feb 1, 2011·Seminars in Arthritis and Rheumatism·Roberto Perez-AlvarezManuel Ramos-Casals
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Sep 22, 2012·AJR. American Journal of Roentgenology·Emma C Ferguson, Eugene A Berkowitz
Jul 24, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Victor Horácio de Souza CostaLucia de Noronha
May 21, 2015·American Society of Clinical Oncology Educational Book·Michael A Postow
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 16, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J NaidooJ D Wolchok
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 30, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yiting GengJingting Jiang
Feb 13, 2016·Cancer Immunology Research·Mizuki NishinoMark M Awad
Mar 2, 2016·Cancer Immunology Research·Jarushka NaidooMario E Lacouture
Jun 4, 2016·Drug Target Insights·Paraskevi FragkouAnna Koumarianou
Jun 15, 2016·American Journal of Respiratory and Critical Care Medicine·Harold R CollardFernando J Martinez
Jun 17, 2016·Annals of the Rheumatic Diseases·Laura C CappelliClifton O Bingham
Jul 13, 2016·The Oncologist·Jeffrey S WeberDirk Schadendorf
Jul 18, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kohei FujitaTadashi Mio
Aug 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria Del CastilloGil Redelman-Sidi
Aug 19, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mizuki NishinoF Stephen Hodi
Aug 28, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·V GounantG Zalcman
Sep 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jarushka NaidooMatthew D Hellmann
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi
Nov 22, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thanyanan Reungwetwattana, Alex A Adjei
Dec 31, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen G ChunJeffrey D Bradley
Feb 19, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Terufumi KatoTomohide Tamura
Apr 7, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ShibakiN Yamamoto
May 18, 2017·The New England Journal of Medicine·Khashayar Esfahani, Wilson H Miller
Jul 1, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D MakariousJ I G Coward

❮ Previous
Next ❯

Software Mentioned

EmpowerStats
radionics
R

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Karthik SureshJarushka Naidoo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Karthik SureshJarushka Naidoo
© 2021 Meta ULC. All rights reserved